MarketBeat on MSN
3 biotech stocks that could benefit from the patent cliff
Biotechnology stocks have seen a spike in merger and acquisition (M&A) activity. In March 2026 alone, there were 10 deals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results